PROF.DR. HASAN SADİ GÜLEÇ    
Name : HASAN SADİ
Surname : GÜLEÇ
E-Mail : sgulec@.ankara.edu.tr
Phone Number : 3125082523
Title : PROF.DR.
Unit : FACULTY OF MEDICINE
Department : Cardiology
Personal Information

Hasan Sadi Güleç, M.D., Cardiologist

Ankara University, School of Medicine

Cardiology Department, Ankara,TURKEY

 

Ankara, 1967

EDUCATION AND TRAINING:

           

 

Graduate

1985-1991                  Ankara University, School of Medicine       Medical Doctor

 

Post Graduate                                                                                            

1992-1997                  Ankara University, School of Medicine       Residency, Cardiology

Cardiology Department                                 

Ankara, Turkey                                            

 

1998- 2000                  Ankara University, School of Medicine      Fellow, Interventional

Cardiology Department                                Cardiology

Ankara, Turkey                                            

 

1999-2000                  Cleveland Clinic                                            Observer

                                   Cardiology Department, Cleveland

Ohio, USA

 

                                                                                 APPOINTMENTS AND POSITIONS:

 

 


Academic

1997                                  Ankara University, School of Medicine       Cardiologist

Cardiology Department

Ankara, Turkey        

 

2000                           Ankara University, School of Medicine       Associate Professor of

                                   Cardiology Department                                Cardiology

                                   Ankara, Turkey

 

2006                           Ankara University, School of Medicine       Professor of Cardiology

                                   Cardiology Department                               

                                   Ankara, Turkey

 

Non-academic

 

1991-1992                  Turkish National Health Service                  General Practitioner

 

1997-2000                  Ankara University, School of Medicine       Staff Physician in

Cardiology Department                                Cardiology 

Ankara, Turkey                    

          

 

                                                                                 MEMBERSHIP IN PROFESSIONAL AND SCIENTIFIC SOCIETIES:

 

 


Turkish Society of Cardiology, Istanbul, Turkey (Member)

Society of Clinical Vascular Biology, Ankara, Turkey (Member)

European Society of Cardiology, Sophia Antipolis Cedex, France (Member)

Turkish Metabolic Syndrome Society (Executive Member)

Working Group on Lipids, Turkish Society of Cardiology (Past President)

                                                                             NATIONAL-INTERNATIONAL MULTICENTER STUDIES:

 

 

 


1.      Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial, Phase III, Co-Investigator

2.      Study Assessing Goals in the Elderly (SAGE), Phase III, Co-Investigator

3.      Clinical Utility of Amlodipine/Atorvastatin to Improve Concomitant Cardiovascular Risk Factors of Hypertension and Dyslipidemia (GEMINI-AALA), Phase III, Co-Investigator

4.      Platelet Inhibition and Patient Outcomes (PLATO), Phase III,  Co-Investigator

5.      Turkish Lipid Study (TULIPS), Principal Investigator

6.      Prospective Urban Rural Epidemiology (PURE) study. Co-Investigator

7.      The prevalence of microalbuminuria and relevant cardiovascular risk factors in Turkish hypertensive patients. (I-SEARCH). Co-Investigator

 

                                                                                PAPERS:

 

 


1.  Relation of acute decompensated heart failure to silent cerebral infarcts in patients with reduced left ventricular ejection fraction.

Ozyuncu N, Gulec S, Kaya CT, Goksuluk H, Tan TS, Vurgun VK, Us E, Erol C.Am J Cardiol. 2019 Mar 15. pii: S0002-9149(19)30301-7. doi: 10.1016/j.amjcard.2019.02.055. [Epub ahead of print] 


2.  Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Mente A, O'Donnell M, Rangarajan S, McQueen M, Dagenais G, Wielgosz A, Lear S, Ah STL, Wei L, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Mony P, Szuba A, Iqbal R, Yusuf R, Mohammadifard N, Khatib R, Yusoff K, Ismail N, Gulec S, Rosengren A, Yusufali A, Kruger L, Tsolekile LP, Chifamba J, Dans A, Alhabib KF, Yeates K, Teo K, Yusuf S. Lancet. 2018 Aug 11;392(10146):496-506. doi: 10.1016/S0140-6736(18)31376-X. Epub 2018 Aug 9.

 

3.      Comparison of Frequency of Silent Cerebral Infarction After Coronary Angiography and Stenting With Transradial Versus Transfemoral Approaches. Göksülük H, Güleç S, Özyüncü N, Kürklü ST, Vurgun VK, Candemir B, Uludağ MG, Öztürk S, Us E, Erol Ç. Am J Cardiol. 2018 Aug 15;122(4):548-553.

 

4.      Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world. Joseph P, Yusuf S, Lee SF, Ibrahim Q, Teo K, Rangarajan S, Gupta R, Rosengren A, Lear SA, Avezum A, Lopez-Jaramillo PGulec S, Yusufali A, Chifamba J, Lanas F, Kumar R, Mohammadifard N, Mohan V, Mony P, Kruger A, Liu X, Guo B, Zhao W, Yang Y, Pillai R, Diaz R, Krishnapillai A, Iqbal R, Yusuf R, Szuba A, Anand SS; PURE INVESTIGATORS.

Heart. 2017 Oct 24. pii: heartjnl-2017-311609. doi: 10.1136/heartjnl-2017-311609. [Epub ahead of print]

 

 

5.      Impact of serum erythropoietin level on collateral vessel development in patients with coronary artery disease.Özyüncü N, Güleç S, Özdöl Ç, Candemir B, Ongun A, Tulunay Kaya C, Erol Ç.

Anatol J Cardiol. 2017 May;17(5):386-391. doi: 10.14744/Anatol J Cardiol.2017.7419. Epub 2017 Mar 9.

 

6.      Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study.

Mente A, Dehghan M, Rangarajan S, McQueen M, Dagenais G, Wielgosz A, Lear S, Li W, Chen H, Yi S, Wang Y, Diaz R, Avezum A, Lopez-Jaramillo P, Seron P, Kumar R, Gupta R, Mohan V, Swaminathan S, Kutty R, Zatonska K, Iqbal R, Yusuf R, Mohammadifard N, Khatib R, Nasir NM, Ismail N, Oguz A, Rosengren A, Yusufali A, Wentzel-Viljoen E, Puoane T, Chifamba J, Teo K, Anand SS, Yusuf S; Prospective Urban Rural Epidemiology (PURE) study investigators.

Lancet Diabetes Endocrinol. 2017 Oct;5(10):774-787. doi: 10.1016/S2213-8587(17)30283-8. Epub 2017 Aug 29.

 

7.      Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study. Miller V, Mente A, Dehghan M, Rangarajan S, Zhang X, Swaminathan S, Dagenais G, Gupta R, Mohan V, Lear S, Bangdiwala SI, Schutte AE, Wentzel-Viljoen E, Avezum A, Altuntas Y, Yusoff K, Ismail N, Peer N, Chifamba J, Diaz R, Rahman O, Mohammadifard N, Lana F, Zatonska K, Wielgosz A, Yusufali A, Iqbal R, Lopez-Jaramillo P, Khatib R, Rosengren A, Kutty VR, Li W, Liu J, Liu X, Yin L, Teo K, Anand S, Yusuf S; Prospective Urban Rural Epidemiology (PURE) study investigators.

Lancet. 2017 Nov 4;390(10107):2037-2049. doi: 10.1016/S0140-6736(17)32253-5. Epub 2017 Aug 29.

 

8.      Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study.Dehghan M, Mente A, Zhang X, Swaminathan S, Li W, Mohan V, Iqbal R, Kumar R, Wentzel-Viljoen E, Rosengren A, Amma LI, Avezum A, Chifamba J, Diaz R, Khatib R, Lear S, Lopez-Jaramillo P, Liu X, Gupta R, Mohammadifard N, Gao N, Oguz A, Ramli AS, Seron P, Sun Y, Szuba A, Tsolekile L, Wielgosz A, Yusuf R, Hussein Yusufali A, Teo KK, Rangarajan S, Dagenais G, Bangdiwala SI, Islam S, Anand SS, Yusuf S; Prospective Urban Rural Epidemiology (PURE) study investigators.

Lancet. 2017 Nov 4;390(10107):2050-2062. doi: 10.1016/S0140-6736(17)32252-3. Epub 2017 Aug 29.

 

9.      Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data.

Attaei MW, Khatib R, McKee M, Lear S, Dagenais G, Igumbor EU, AlHabib KF, Kaur M, Kruger L, Teo K, Lanas F, Yusoff K, Oguz A, Gupta R, Yusufali AM, Bahonar A, Kutty R, Rosengren A, Mohan V, Avezum A, Yusuf R, Szuba A, Rangarajan S, Chow C, Yusuf S; PURE study investigators.

Lancet Public Health. 2017 Sep;2(9):e411-e419. doi: 10.1016/S2468-2667(17)30141-X. Epub 2017 Sep 5.

 

10.   Cost of heart failure management in Turkey: results of a Delphi Panel.

Aras D, Aydoğdu S, Bozkurt E, Çavuşoğlu Y, Eren M, Erol Ç, Güleç S, Kızılırmak P, Öngen Z, Özdemir O, Saylan M, Tokgözoğlu L, Yeter E, Yılmaz MB.

Anatol J Cardiol. 2016 Aug;16(8):554-62. doi: 10.14744/AnatolJCardiol.2016.6999.

 

11.   Cardiac metastasis of synovial sarcoma presenting with superior vena cava syndrome.

Özyüncü N, Turan N, Gerede DM, Özçınar E, Güleç S, Perçinel S, Erol Ç.

Anatol J Cardiol. 2016 Jun;16(6):E11. doi: 10.14744/AnatolJCardiol.2016.7126. No abstract available.

 

12.   Usefulness of Neuron-Specific Enolase to Detect Silent Neuronal Ischemia After Percutaneous Coronary Intervention.

Goksuluk H, Gulec S, Ozcan OU, Gerede M, Vurgun VK, Ozyuncu N, Erol C.

Am J Cardiol. 2016 Jun 15;117(12):1917-20. doi: 10.1016/j.amjcard.2016.03.037. Epub 2016 Apr 6.

 

13.   Assessing global risk factors for non-fatal injuries from road traffic accidents and falls in adults aged 35-70 years in 17 countries: a cross-sectional analysis of the Prospective Urban Rural Epidemiological (PURE) study.

Raina P, Sohel N, Oremus M, Shannon H, Mony P, Kumar R, Li W, Wang Y, Wang X, Yusoff K, Yusuf R, Iqbal R, Szuba A, Oguz A, Rosengren A, Kruger A, Chifamba J, Mohammadifard N, Darwish EA, Dagenais G, Diaz R, Avezum A, Lopez-Jaramillo P, Seron P, Rangarajan S, Teo K, Yusuf S; PURE Investigators.

Inj Prev. 2016 Apr;22(2):92-8. doi: 10.1136/injuryprev-2014-041476. Epub 2015 Oct 28.

 

14.   Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.

Khatib R, McKee M, Shannon H, Chow C, Rangarajan S, Teo K, Wei L, Mony P, Mohan V, Gupta R, Kumar R, Vijayakumar K, Lear SA, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Yusoff K, Ismail N, Kazmi K, Rahman O, Rosengren A, Monsef N, Kelishadi R, Kruger A, Puoane T, Szuba A, Chifamba J, Temizhan A, Dagenais G, Gafni A, Yusuf S; PURE study investigators.

Lancet. 2016 Jan 2;387(10013):61-9. doi: 10.1016/S0140-6736(15)00469-9. Epub 2015 Oct 20.

 

15.   Alcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: a prospective cohort study.

Smyth A, Teo KK, Rangarajan S, O'Donnell M, Zhang X, Rana P, Leong DP, Dagenais G, Seron P, Rosengren A, Schutte AE, Lopez-Jaramillo P, Oguz A, Chifamba J, Diaz R, Lear S, Avezum A, Kumar R, Mohan V, Szuba A, Wei L, Yang W, Jian B, McKee M, Yusuf S; PURE Investigators.

Lancet. 2015 Nov 14;386(10007):1945-54. doi: 10.1016/S0140-6736(15)00235-4. Epub 2015 Sep 17.

 

16.   Comparison of a qualitative measurement of heart-type fatty acid-binding protein with other cardiac markers as an early diagnostic marker in the diagnosis of non-ST-segment elevation myocardial infarction.

Gerede DM, Güleç S, Kiliçkap M, Kaya CT, Vurgun VK, Özcan ÖU, Göksülük H, Erol Ç.

Cardiovasc J Afr. 2015 Nov-Dec;26(6):204-9. doi: 10.5830/CVJA-2015-028. Epub 2015 Jul 14.

 

17.   Assessment of efficacy of single dose acetylsalicylic acid over a 24-hour period.

Baha RM, Özdöl Ç, Güleç S, Erol Ç.

Turk Kardiyol Dern Ars. 2015 Jul;43(5):443-9. doi: 10.5543/tkda.2015.78380.

 

18.   Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study.

Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, Seron P, Ahmed SH, Rosengren A, Kelishadi R, Rahman O, Swaminathan S, Iqbal R, Gupta R, Lear SA, Oguz A, Yusoff K, Zatonska K, Chifamba J, Igumbor E, Mohan V, Anjana RM, Gu H, Li W, Yusuf S; Prospective Urban Rural Epidemiology (PURE) Study investigators.

Lancet. 2015 Jul 18;386(9990):266-73. doi: 10.1016/S0140-6736(14)62000-6. Epub 2015 May 13.

 

19.   Impact of metabolic syndrome on development of contrast-induced nephropathy after elective percutaneous coronary intervention among nondiabetic patients.

Ozcan OU, Adanir Er H, Gulec S, Ustun EE, Gerede DM, Goksuluk H, Tulunay Kaya C, Erol C.

Clin Cardiol. 2015 Mar;38(3):150-6. doi: 10.1002/clc.22364.

 

20.   Abdominal obesity perception in Turkish population.

Oguz A, Temizhan A, Altuntas Y, Karsidag K, Gulec S, Telci Caklili O.

J Nutr Educ Behav. 2015 Mar-Apr;47(2):e11. doi: 10.1016/j.jneb.2014.12.009. No abstract available.

 

21.   Heterozygous familial hypercholesterolemia.

Özcan ÖU, Güleç S.

Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 2:10-8. Review. Turkish.

 

22.   Valsartan after myocardial infarction.

Güleç S.

Anadolu Kardiyol Derg. 2014 Dec;14 Suppl 2:S9-13. doi: 10.5152/akd.2014.00002. Review.

 

23.   Effect of angiotensin converting enzyme inhibitors on periprocedural myocardial infarction in patients with metabolic syndrome.

Ozcan OU, Ustun EE, Gulec S, Gerede DM, Goksuluk H, Vurgun VK, Kaya CT, Erol C.

Cardiol J. 2015;22(3):323-9.

 

24.   Cardiovascular risk and events in 17 low-, middle-, and high-income countries.

Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, Bo J, Lou Q, Lu F, Liu T, Yu L, Zhang S, Mony P, Swaminathan S, Mohan V, Gupta R, Kumar R, Vijayakumar K, Lear S, Anand S, Wielgosz A, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Yusoff K, Ismail N, Iqbal R, Rahman O, Rosengren A, Yusufali A, Kelishadi R, Kruger A, Puoane T, Szuba A, Chifamba J, Oguz A, McQueen M, McKee M, Dagenais G; PURE Investigators.

N Engl J Med. 2014 Aug 28;371(9):818-27. doi: 10.1056/NEJMoa1311890.

 

25.   Urinary sodium and potassium excretion, mortality, and cardiovascular events.

O'Donnell M, Mente A, Rangarajan S, McQueen MJ, Wang X, Liu L, Yan H, Lee SF, Mony P, Devanath A, Rosengren A, Lopez-Jaramillo P, Diaz R, Avezum A, Lanas F, Yusoff K, Iqbal R, Ilow R, Mohammadifard N, Gulec S, Yusufali AH, Kruger L, Yusuf R, Chifamba J, Kabali C, Dagenais G, Lear SA, Teo K, Yusuf S; PURE Investigators.

N Engl J Med. 2014 Aug 14;371(7):612-23. doi: 10.1056/NEJMoa1311889. Erratum in: N Engl J Med. 2014 Sep 25;371(13):1267.

 

26.   Association of urinary sodium and potassium excretion with blood pressure.

Mente A, O'Donnell MJ, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, Morrison H, Li W, Wang X, Di C, Mony P, Devanath A, Rosengren A, Oguz A, Zatonska K, Yusufali AH, Lopez-Jaramillo P, Avezum A, Ismail N, Lanas F, Puoane T, Diaz R, Kelishadi R, Iqbal R, Yusuf R, Chifamba J, Khatib R, Teo K, Yusuf S; PURE Investigators.

N Engl J Med. 2014 Aug 14;371(7):601-11. doi: 10.1056/NEJMoa1311989.

 

27.   Misinterpretation of the HAS-BLED bleeding score by end-users.

Gulec S.

Thromb Res. 2014 Jul;134(1):203. doi: 10.1016/j.thromres.2014.05.002. Epub 2014 May 10. No abstract available.

 

28.   Steroid use in kidney transplant recipients presented with acute myocardial infarction.

Ozcan OU, Gulec S, Gursoy E, Celebi ZK, Erol C.

Heart Lung. 2014 Jul-Aug;43(4):289-91. doi: 10.1016/j.hrtlng.2014.04.006. Epub 2014 May 22.

 

29.   Diagnosis and treatment of stage 1 hypertension: which guidelines should we follow?

Gulec S. J Am Soc Hypertens. 2014 May;8(5):358-9. doi: 10.1016/j.jash.2014.02.005. Epub 2014 Feb 21. No abstract available.

 

  1. Possible limitations of using the HAS-BLED bleeding score in real life settings. Gulec S.

Thromb Res. 2014 Jan 27. pii: S0049-3848(14)00051-6. doi: 10.1016/j.thromres.2014.01.027. [Epub ahead of print]

 

  1. Early diagnosis saves lives: focus on patients with hypertension . Gulec, S. Kidney Int Suppl 2013;3:332-34
  2. Marked Narrowing of Right Heart Chambers Due to Compression by Giant Hepatic Hydatid Cyst. Ozcan OU, Er HA, Turhan S, Gulec S, Sogut G, Kozluca V, Erol C. Echocardiography. 2013 Jul 30. doi: 10.1111/echo.12335. 
  3.   Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: The Prospective Urban Rural Epidemiology (PURE) study.Teo K, Lear S, Islam S, Mony P, Dehghan M, Li W, Rosengren A, Lopez-Jaramillo P, Diaz R, Oliveira G, Miskan M, Rangarajan S, Iqbal R, Ilow R, Puone T, Bahonar A, Gulec S, Darwish EA, Lanas F, Vijaykumar K, Rahman O, Chifamba J, Hou Y, Li N, Yusuf S; PURE Investigators. JAMA 2013;309:1613-21
  4. Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. MTHFR Studies Collaborative Group. PLoS Med. 2012 Feb;9(2):e1001177. Epub 2012 Feb 21.
  5. The prevalence of microalbuminuria and relevant cardiovascular risk factors in Turkish hypertensive patients. Turkish investigators of the i-SEARCH study. Turk Kardiyol Dern Ars. 2011 Dec;39(8):635-45. doi: 10.5543/tkda.2011.01477.
  6. Effect of atorvastatin on erectile functions in comparison with regular tadalafil use. A prospective single-blind study. Gokce MI, Gülpınar O, Oztürk E, Güleç S, Yaman O. Int Urol Nephrol. 2012 Jan 18. [Epub ahead of print]
  7. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Prospective Urban Rural Epidemiology (PURE) Study Investigators. Lancet. 2011 Oct 1;378(9798):1231-43. Epub 2011 Aug 26.
  8. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D; ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees, Bax J, Vahanian A, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Filippatos G, Funck-Brentano C, Hasdai D, Hobbs R, Hoes A, Kearney P, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vardas P, Widimsky P, Windecker S, Funck-Brentano C, Poldermans D, Berkenboom G, De Graaf J, Descamps O, Gotcheva N, Griffith K, Guida GF, Gulec S, Henkin Y, Huber K, Kesaniemi YA, Lekakis J, Manolis AJ, Marques-Vidal P, Masana L, McMurray J, Mendes M, Pagava Z, Pedersen T, Prescott E, Rato Q, Rosano G, Sans S, Stalenhoef A, Tokgozoglu L, Viigimaa M, Wittekoek ME, Zamorano JL. Eur Heart J. 2011 Jul;32(14):1769-818. Epub 2011 Jun 28.
  9. Very late drug-eluting stent thrombosis in a patient with an INR of 4.4. Candemir B, Güleç S, Ozdemir AO, Kumbasar D. Turk Kardiyol Dern Ars. 2010 Dec;38(8):561-3.

 

40      [Renin inhibition in hypertension]. Güleç S. Turk Kardiyol Dern Ars. 2009 Oct;37 Suppl 7:15-22.

41.      [The JUPITER trial: a new approach in primary prevention].Güleç S. Turk Kardiyol Dern Ars. 2009 Apr;37 Suppl 4:18-26. Review.

42.   The relation between endothelial dependent flow mediated dilation of the brachial artery and coronary collateral development - a cross sectional study. Ozdemir AO, Gulec S, Uslu N, Kaya CT, Ozdol C, Turhan S, Atmaca Y, Altin T, Erol C. Cardiovasc Ultrasound. 2009 Jun 15;7:25.

43.   [Global risk and objectives in cardiovascular diseases]. Güleç S.Turk Kardiyol Dern Ars. 2009 Mar;37 Suppl 2:1-10.

44.   [Aspirin in patients undergoing percutaneous coronary intervention]. Güleç S. Anadolu Kardiyol Derg. 2007 Dec;7 Suppl 2:9-13. Review.

45.   The effect of cardiac rehabilitation on quality of life, anxiety and depression in patients with congestive heart failure. A randomized controlled trial, short-term results. Kulcu DG, Kurtais Y, Tur BS, Gülec S, Seckin B.

46.   Glu298Asp polymorphism of the eNOS gene is associated with coronary collateral development. Gulec S, Karabulut H, Ozdemir AO, Ozdol C, Turhan S, Altin T, Tutar E, Genc Y, Erol C. Atherosclerosis. 2008 Jun;198(2):354-9. Epub 2007 Nov 19.

47.   Electrocardiographic abnormalities in patients with organic erectile dysfunction: comparison with an age-matched control group. Tokgoz H, Yaman O, Gulec S, Soyupek S, Sahinli S, Anafarta K. Int Urol Nephrol. 2008;40(2):373-6.

48.   The relationship of chronic angiotensin converting enzyme inhibitor use and coronary collateral vessel development. Altin T, Kilickap M, Tutar E, Turhan S, Atmaca Y, Gulec S, Oral D, Erol C. Int Heart J. 2007 Jul;48(4):435-42.

49.   Relationship between angiotensin-converting enzyme gene polymorphism and severity of aortic valve calcification. Ertas FS, Hasan T, Ozdol C, Gulec S, Atmaca Y, Tulunay C, Karabulut H, Kocum HT, Dincer I, Kose KS, Erol C. Mayo Clin Proc. 2007 Aug;82(8):944-50.

50.   Efficacy and safety of extended-release fluvastatin in Turkish patients with hypercholesterolaemia: TULIPS (Turkish Lipid Study). Ilerigelen B, Uresin Y, San M, Kültürsay H, Güneri S, Serdar OA, Güleç S, Pençedemir H; TULIPS Investigators. Curr Med Res Opin. 2007 May;23(5):1093-102.

51.   The effect of high-dose aspirin pre-treatment on the incidence of myonecrosis following elective coronary stenting. Gulec S, Ozdol C, Vurgun K, Selcuk T, Turhan S, Duzen V, Temizhan A, Ozturk S, Ozdemir AO, Erol C. Atherosclerosis. 2008 Mar;197(1):171-6. Epub 2007 Apr 16.

52.   The association between androgen levels and premature coronary artery disease in men. Turhan S, Tulunay C, Güleç S, Ozdöl C, Kilickap M, Altin T, Gerede M, Erol C. Coron Artery Dis. 2007 May;18(3):159-62.

53.   Naproxen treatment prevents periprocedural inflammatory response but not myocardial injury after percutaneous coronary intervention. Ozdol C, Gulec S, Rahimov U, Atmaca Y, Turhan S, Erol C. Thromb Res. 2007;119(4):453-9. Epub 2006 Dec 8.

54.   Unrecognized side effect of statin treatment: unilateral blepharoptosis. Ertas FS, Ertaş NM, Gulec S, Atmaca Y, Tanju S, Sener C, Erol C. Ophthal Plast Reconstr Surg. 2006 May-Jun;22(3):222-4.

55.   Elevated levels of C-reactive protein are associated with impaired coronary collateral development. Gulec S, Ozdemir AO, Maradit-Kremers H, Dincer I, Atmaca Y, Erol C. Eur J Clin Invest. 2006 Jun;36(6):369-75.

56.   Myonecrosis after elective percutaneous coronary intervention: effect of clopidogrel-statin interaction. Gulec S, Ozdol C, Rahimov U, Atmaca Y, Kumbasar D, Erol C. J Invasive Cardiol. 2005 Nov;17(11):589-93.

57.   Angiographic evaluation of myocardial perfusion in patients with syndrome X. Atmaca Y, Ozdemir AO, Ozdol C, Oguz D, Gulec S, Kumbasar D, Erol C. Am J Cardiol. 2005 Sep 15;96(6):803-5.

58.   Effect of direct stent implantation on QTc dispersion. Atmaca Y, Ozdol C, Ertas F, Altin T, Gülec S, Oral D. Angiology. 2005 Mar-Apr;56(2):143-9.

59.   Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation. Tutar E, Ozcan M, Kilickap M, Gülec S, Aras O, Pamir G, Oral D, Dandelet L, Key NS. Circulation. 2003 Sep 30;108(13):1581-4. Epub 2003 Sep 15.

60.   A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis. Erdogan MF, Güleç S, Tutar E, Başkal N, Erdogan G. Thyroid. 2003 Feb;13(2):205-9.

61.   Angiographic assessment of myocardial perfusion in patients with isolated coronary artery ectasia. Gulec S, Atmaca Y, Kilickap M, Akyürek O, Aras O, Oral D. Am J Cardiol. 2003 Apr 15;91(8):996-9, A7. No abstract available.

62.   The prevention of minor myocardial injury with ticlopidine pretreatment in patients undergoing elective coronary stenting. Atmaca Y, Gülec S, Ertas F, Pamir G, Oral D. Int J Cardiol. 2003 Feb;87(2-3):151-7.

63.   Comparison of clopidogrel versus ticlopidine for prevention of minor myocardial injury after elective coronary stenting. Atmaca Y, Dandachi R, Gülec S, Dincer I, Oral D. Int J Cardiol. 2003 Feb;87(2-3):143-9.

64.   Deletion polymorphism of the angiotensin I converting enzyme gene is a potent risk factor for coronary artery ectasia. Gülec S, Aras O, Atmaca Y, Akyürek O, Hanson NQ, Sayin T, Tsai MY, Akar N, Oral D. Heart. 2003 Feb;89(2):213-4. No abstract available.

65.   Effect of direct stent implantation on minor myocardial injury. Atmaca Y, Ertas F, Gülec S, Dincer I, Oral D. J Invasive Cardiol. 2002 Aug;14(8):443-6.

66.   Direct stent implantation in acute coronary syndrome. Atmaca Y, Altin T, Ozdöl Sadi C, Guleç S, Pamir G, Oral D. J Invasive Cardiol. 2002 Jun;14(6):308-12.

67.   Endothelial nitric oxide gene polymorphism (Glu298Asp) is not associated with coronary artery disease in Turkish population. Aras O, Hanson NQ, Bakanay SM, Tsai MY, Gulec S. Thromb Haemost. 2002 Feb;87(2):347-9. No abstract available.

68.   Exercise-induced myocardial ischemia in patients with coronary artery ectasia without obstructive coronary artery disease. Sayin T, Döven O, Berkalp B, Akyürek O, Güleç S, Oral D. Int J Cardiol. 2001 Apr;78(2):143-9.

69.   Methylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction. Gülec S, Aras O, Akar E, Tutar E, Omürlü K, Avci F, Dinçer I, Akar N, Oral D. Clin Cardiol. 2001 Apr;24(4):281-4.

70.   Hyperhomocysteinemia and restenosis. Kumbasar SD, Dinçer I, Ertas F, Gülec S, Erol C, Akyürek O, Kiliçkap M, Oral D, Sipahi E, Laleli Y. J Cardiovasc Risk. 2001 Feb;8(1):9-13.

71.   Relation between the insertion/deletion polymorphism of the angiotensin I converting enzyme gene and restenosis after coronary stenting. Gürlek A, Güleç S, Karabulut H, Bokesoy I, Tutar E, Pamir G, Alpman A, Toydemir R, Aras O, Oral D. J Cardiovasc Risk. 2000 Dec;7(6):403-7.

72.   Atrial sensing performance of a single-lead VDD pacing system during physical activities. Ertaş F, Karaoğuz R, Güldal M, Kumbasar D, Güleç S, Oral D. J Electrocardiol. 2000 Jul;33(3):253-60.

73.   Left atrial appendage function in patients with different pacing modes. Ertaş F, Güleç S, Dinçer I, Erol C, Tutar E, Güldal M, Karaoğuz R, Oral D. Int J Cardiol. 2000 Apr 28;73(2):135-41.

74.   HLA-B40-, HLA-Cw3-, and HLA-DR5-associated susceptibility to amiodarone-induced thyroid dysfunction. Erdoğan MF, Güleç S, Tutar E, Güldal M, Başkal N, Erdoğan G. Thyroid. 2000 Apr;10(4):369-70. Review. No abstract available.

75.   A case of type IV dual left anterior descending artery associated with anomalous origin of the left circumflex artery in the presence of coronary atherosclerosis. Tutar E, Gülec S, Pamir G, Alpman A, Omürlü K, Oral D. J Invasive Cardiol. 1999 Oct;11(10):631-4.

76.   Bronchial hyperreactivity in patients with mitral stenosis before and after successful percutaneous mitral balloon valvulotomy. Gülec S, Ertas F, Tutar E, Demirel Y, Karaoguz R, Omurlu K, Oral D. Chest. 1999 Dec;116(6):1582-6.

77.   Echocardiographic evaluation of left ventricular diastolic function in chronic cor pulmonale. Tutar E, Kaya A, Güleç S, Ertaş F, Erol C, Ozdemir O, Oral D. Am J Cardiol. 1999 May 1;83(9):1414-7, A9.

78.   Value of ST-segment depression during paroxysmal supraventricular tachycardia in the diagnosis of coronary artery disease. Güleç S, Ertaş F, Karaoŏuz R, Güldal M, Alpman A, Oral D. Am J Cardiol. 1999 Feb 1;83(3):458-60, A10.

79.   Exercise performance in patients with dilated cardiomyopathy: relationship to resting left ventricular function. Güleç S, Ertaş F, Tutar E, Cağlar N, Akgün G, Alpman A, Oral D. Int J Cardiol. 1998 Aug;65(3):247-53.